Washington University Podcasts Washington University RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

ASCO 2016 update on ALK+ lung cancer agents
Dr. Ramaswamy Govindan, MD of Washington University Medical School gives an update on ALK+ lung cancer agents at ASCO 2016 Author: ASCO2016 Added: 06/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 23, 2016 Category: Cancer & Oncology Source Type: podcasts

ASFH New IOL Ideas at the 2016 ASCRS Annual Meeting
Guests: Anjali Bhorade, MD Assistant Professor of Ophthalmology Washington University School of Medicine St. Louis, MO Mark Packer, MD Boulder, CO (Source: As Seen From Here)
Source: As Seen From Here - June 19, 2016 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts

What is V20 and Why Do Radiation Dose & Field Size Matter?
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines the V20 standard for lung radiation and outlines the advantages of limiting dose and field size in lung radiati... Author: cancergrace Added: 02/04/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 4, 2016 Category: Cancer & Oncology Source Type: podcasts

High vs. Standard Dose Chest Radiation in Stage III Lung Cancer
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides trial evidence showing that patients may not benefit from high dose chest radiation therapy vs. standard dose ... Author: cancergrace Added: 02/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 3, 2016 Category: Cancer & Oncology Source Type: podcasts

SBRT for Oligometastatic Lung Cancer
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, defines oligometastatic lung cancer and describes the recent trend toward the use of stereotactic body radiation therap... Author: cancergrace Added: 02/02/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2016 Category: Cancer & Oncology Source Type: podcasts

SBRT for Medically Inoperable Stage I Lung Cancer
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, describes the history and current use of stereotactic radiation therapy for inoperable lung lesions. http://cancergr...... Author: cancergrace Added: 02/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2016 Category: Cancer & Oncology Source Type: podcasts

What is Stereotactic Radiosurgery/Radiation Therapy to the Brain or Body?
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, describes the use of stereotactic radiosurgery and stereotactic radiation therapy. http://cancergrace.org/lung...... Author: cancergrace Added: 02/01/2016 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2016 Category: Cancer & Oncology Source Type: podcasts

SBRT as a Potential Alternative for Fit Patients with Early Stage Lung Cancer
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, provides evidence for the use of stereotactic body radiation therapy as an alternative to surgery for operable early st... Author: cancergrace Added: 01/28/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 28, 2016 Category: Cancer & Oncology Source Type: podcasts

iwNHL 2015: Biology of diffuse large B-cell lymphoma
At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Catherine M. Bollard, MBChB, MD, FRACP, FRCPA, of Children's National Health System and The George Washington University, Wa... Author: VJHemOnc Added: 11/22/2015 (Source: Oncology Tube)
Source: Oncology Tube - November 23, 2015 Category: Cancer & Oncology Source Type: podcasts

Dr. Govindan on Genomic Characterization of Large-Cell Neuroendocrine Lung Tumors
Ramaswamy Govindan, MD, medical oncologist, Washington University School of Medicine in St. Louis, discusses a talk given at the 16th World Conference on Lung Cancer. More at http://onclive.com/... Author: onclivetv Added: 09/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 11, 2015 Category: Cancer & Oncology Source Type: podcasts

ASCO 2014: The Impact of Race and Socio-Economic Status on Survival in Multiple Myeloma
Mark A. Fiala, BS, CCRN Washington University School of Medicine Division of Oncology, Department of Medicine Saint Louis, MO, USA The Impact of Race and Socio-Economic Status on Survival in Mul... Author: InternationalMyelomaFoundation Added: 09/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2015 Category: Cancer & Oncology Source Type: podcasts

What Experts Have Learned About Pruritis (Itching) in MPNs
Is there a remedy for itching in MPN patients? MPN expert Dr. Stephen Oh from Washington University School of Medicine addresses the often bothersome issue of itching in patients with myeloproliferati... Author: P2Professional Added: 09/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2015 Category: Cancer & Oncology Source Type: podcasts

What Experts Have Learned About Pruritis (Itching) in MPNs
Is there a remedy for itching in MPN patients? MPN expert Dr. Stephen Oh from Washington University School of Medicine addresses the often bothersome issue of itching in patients with myeloproliferati... Author: patientpower Added: 09/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 10, 2015 Category: Cancer & Oncology Source Type: podcasts

Testing and Prognosis for Genetic Mutations in MPNs
MPN experts Dr. Stephen Oh from Washington University School of Medicine and Dr. Brady Stein from Northwestern Medicine examine genetic testing as it relates to the prognosis and treatment of myelopro... Author: patientpower Added: 08/25/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 26, 2015 Category: Cancer & Oncology Source Type: podcasts